Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide + Bevacizumab vs nab-Paclitaxel + Carboplatin + Bevacizumab in Stage IV Melanoma
NCT00626405Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Polymer-based Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, nab-paclitaxel in melanoma, sponsored by Cancer and Leukemia Group B. Started Aug 2008; status: completed.
02
Drugs
bevacizumabnab-paclitaxel
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00626405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626405.